ClinicalTrials.Veeva

Menu

Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours (QUALINETS)

Ipsen logo

Ipsen

Status

Completed

Conditions

Gastrointestinal Neuroendocrine Tumours

Study type

Observational

Funder types

Industry

Identifiers

NCT02853422
IPS-ANT- 2015-01 (Other Identifier)
A-ES-52030-351

Details and patient eligibility

About

The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.

Enrollment

199 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with a diagnosis of gastrointestinal endocrine tumour.
  • Patient able to read and understand the study questionnaires.
  • Patient who has given informed consent in writing to take part in the study.

Exclusion criteria

  • Patient who is taking part in another clinical study during the study.
  • Patients with another serious malignancy.
  • Patients unable to meet the requirements of the protocol (non-compliant patients or those unfit to answer the questionnaires).

Trial contacts and locations

32

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems